OMI Owens & Minor

Owens & Minor, Inc. is a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services to deliver significant and sustained value across the breadth of the industry – from acute care to patients in their home. Aligned to its Mission of Empowering Its Customers to Advance HealthcareTM, more than 15,000 global teammates serve over 4,000 healthcare industry customers. A vertically-integrated, predominantly Americas-based footprint enables Owens & Minor to reliably supply its self-manufactured surgical and PPE products. This seamless value chain integrates with a portfolio of products representing 1,200 branded suppliers. Operating continuously since 1882 from its headquarters in Richmond, Virginia, Owens & Minor has grown into a FORTUNE 500 company with operations located across North America, Asia, Europe and Latin America.

Company profile

Edward Pesicka
Fiscal year end
Former names
IRS number

OMI stock data



24 Feb 21
18 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 134.51M 134.51M 134.51M 134.51M 134.51M 134.51M
Cash burn (monthly) 30.99M (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn)
Cash used (since last report) 112.17M n/a n/a n/a n/a n/a
Cash remaining 22.33M n/a n/a n/a n/a n/a
Runway (months of cash) 0.7 n/a n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
8 Apr 21 Jochims Jeffrey T Common Stock Payment of exercise Dispose F No No 37.42 4,967 185.87K 123,469
5 Apr 21 Shana Carol Neal Common Stock Sell Dispose S No Yes 38.17 21,511 821.07K 134,585
5 Apr 21 Christopher M Lowery Common Stock Sell Dispose S No Yes 38.541 3,140 121.02K 311,387
5 Apr 21 Christopher M Lowery Common Stock Sell Dispose S No Yes 37.726 9,674 364.96K 314,527
5 Apr 21 Christopher M Lowery Common Stock Sell Dispose S No Yes 38.547 3,458 133.3K 324,201
5 Apr 21 Christopher M Lowery Common Stock Sell Dispose S No Yes 37.734 11,806 445.49K 327,659
31 Mar 21 Mark F Mcgettrick Phantom Stock Common Stock Grant Aquire A No No 37.59 6 225.54 107,795
31 Mar 21 Moore Eddie N JR Phantom Stock Common Stock Grant Aquire A No No 37.59 2 75.18 28,816

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

88.3% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 234 207 +13.0%
Opened positions 65 46 +41.3%
Closed positions 38 24 +58.3%
Increased positions 73 53 +37.7%
Reduced positions 71 77 -7.8%
13F shares
Current Prev Q Change
Total value 1.76B 1.36B +28.8%
Total shares 64.88M 54.47M +19.1%
Total puts 369.8K 491.6K -24.8%
Total calls 699.4K 1.35M -48.0%
Total put/call ratio 0.5 0.4 +44.8%
Largest owners
Shares Value Change
BLK Blackrock 11.39M $307.97M +17.9%
Vanguard 5.92M $160.05M +21.2%
Dimensional Fund Advisors 4.38M $118.53M +0.5%
FMR 3.23M $87.44M +35915155.6%
Renaissance Technologies 3.08M $83.33M +0.8%
Wellington Management 2.98M $80.73M +8013.1%
STT State Street 2.6M $70.45M +5.3%
Citadel Advisors 1.55M $41.91M +151.7%
Geode Capital Management 1.26M $34.21M +25.1%
IVZ Invesco 1.24M $33.62M +20.0%
Largest transactions
Shares Bought/sold Change
FMR 3.23M +3.23M +35915155.6%
Wellington Management 2.98M +2.95M +8013.1%
BLK Blackrock 11.39M +1.73M +17.9%
JPM JPMorgan Chase & Co. 520.48K -1.56M -75.0%
Vanguard 5.92M +1.03M +21.2%
Citadel Advisors 1.55M +933.76K +151.7%
GS Goldman Sachs 1.02M +711.77K +227.9%
Arrowstreet Capital, Limited Partnership 0 -493.18K EXIT
Iron Triangle Partners 454.42K +454.42K NEW
BAC Bank Of America 971K +442.66K +83.8%

Financial report summary

  • We face competition and accelerating pricing pressure.
  • Our operating income is dependent on certain significant domestic suppliers.
  • An inability to obtain key components, raw materials or manufactured products from third parties may have a material adverse effect on our Global Products segment.
  • Our results of operations may suffer upon the bankruptcy, insolvency, or other credit failure of a customer that has a substantial amount owed to us.
  • Changing conditions in the United States healthcare industry may impact our results of operations.
  • We may not be able to refinance, extend or repay our substantial indebtedness which would have a material adverse affect on our financial condition.
  • Our variable rate indebtedness subjects us to interest rate risk, which could cause our indebtedness service obligations to increase significantly.
  • Our credit facilities and our existing notes have restrictive covenants that could limit our financial flexibility.
  • We may incur product liability losses, litigation liability, product recalls, safety alerts or regulatory action associated with the products that we source, assemble, manufacture and sell which can be costly and disruptive to our business.
  • We must obtain clearance or approval from the appropriate regulatory authorities prior to introducing a new product or a modification to an existing product. The regulatory clearance process may result in substantial costs, delays and limitations on the types and uses of products we can bring to market, any of which could have a material adverse effect on our business.
  • Our business may be adversely affected if we are unable to adequately establish, maintain, protect and enforce our intellectual property and proprietary rights or prevent third parties from making unauthorized use of such rights.
  • We may become subject to litigation brought by third parties claiming infringement, misappropriation or other violation by us of their intellectual property rights.
  • Our business and operations depend on the proper functioning of critical facilities, supply chain and distribution networks.
  • We are subject to stringent regulatory and licensing requirements.
  • Compliance with the terms and conditions of Byram’s Corporate Integrity Agreement requires significant resources and, if we fail to comply, we could be subject to penalties or excluded from participation in government healthcare programs, which could seriously harm our results of operations, liquidity and financial condition.
  • General economic conditions may adversely affect demand for our products and services.
  • Our continued success is substantially dependent on positive perceptions of our reputation.
  • Our inability to adequately integrate acquisitions could have a material adverse effect on our operations.
  • Our ability to attract and retain talented and qualified teammates is critical to our success and competitiveness.
Management Discussion
  • The change in net revenue for the year ended December 31, 2020 reflected the impact of lower distribution revenues as a result of customer non-renewals that occurred in 2019 and a reduction in elective surgical procedures primarily due to the impact of COVID-19. These were partially offset by revenue growth in Global Products from increased demand for PPE and growth in Byram, our Home Healthcare business. Foreign currency translation had a $2.6 million favorable impact on net revenue for the year ended December 31, 2020 as compared to the prior year.
  • Cost of goods sold includes the cost of the product (net of supplier incentives and cash discounts) and all costs incurred for shipments of products from manufacturers to our distribution centers for all customer arrangements where we are the primary obligor and bear risk of general and physical inventory loss. These are sometimes referred to as distribution contracts. Cost of goods sold also includes direct and certain indirect labor, material and overhead costs associated with our Global Products business. There is no cost of goods sold associated with our fee-for-service arrangements. Cost of goods sold compared to prior year reflects changes in sales activity, including sales mix.
  • Gross margin for the year ended December 31, 2020 was impacted by improved sales mix and productivity, operating efficiencies in Global Products and a favorable impact from foreign currency translation of $7.3 million.
Content analysis
H.S. freshman Avg
New words: accident, accidental, accused, addressed, adequacy, adjudication, Aid, allege, alleviate, alter, analyst, attestation, Beck, Bingham, breakage, broader, brought, carryback, CBA, cease, Channel, charitable, Clair, cleaning, compel, conducive, confidentiality, consecutive, COO, court, creativity, culture, cybersecurity, dental, depression, disability, disagree, disease, divided, domain, double, DPA, drew, Dublin, duration, dynamic, embrace, EmployerIdentification, empower, estate, ethical, expedite, expended, fabric, family, feedback, fight, fostering, freight, Guaranteed, Gwendolyn, heart, heightened, HHS, imposition, influence, inhibit, input, Interbank, invalidated, judicial, Lastly, Lebanon, LIBOR, lieu, live, London, Malaysian, mandated, manmade, matter, merit, methodology, Mexican, misappropriated, misappropriation, mission, mixture, Mt, NOL, NOPA, ofincorporation, OUS, outlook, output, PA, peso, philanthropic, PPE, preference, presidential, pride, purpose, quarantine, ramping, rapidly, ratably, real, recommended, recruit, referencing, repaid, replenish, reserve, reserved, resolve, respirator, retooling, rewarded, rewarding, ringgit, Riordan, safe, sea, sick, skilled, solicit, St, stockpile, strongly, subsidizing, Subtopic, sudden, summarized, surrender, taxation, temperature, terminology, thereon, threatened, tranche, transmission, travel, treat, Treaty, twelve, underwriting, unintended, virtual, vision, voice, Walden, week, wholly, worsening
Removed: allocate, amortizing, assigned, authorization, Brexit, British, cancelable, case, CEC, commenced, commonly, condensed, conform, consolidating, conventional, deal, deductible, deep, Employer, enteral, establishment, executed, finite, historic, intense, largely, lessee, liquid, moving, Pound, Prime, put, recast, rent, retained, ROU, salary, scope, select, simplify, standardization, tangible, timeframe, withdrawal, writedown